Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Influenza A virus | Nonstructural protein 1 | Starlite/ChEMBL | No references |
Species | Potential target | Known druggable target | Length | Alignment span | Identity |
---|---|---|---|---|---|
Mycobacterium tuberculosis | Hypothetical protein | Nonstructural protein 1 | 230 aa | 202 aa | 23.8 % |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Loa Loa (eye worm) | serotonin transporter b | 0.2421 | 1 | 1 |
Loa Loa (eye worm) | norepinephrine transporter | 0.2421 | 1 | 1 |
Echinococcus multilocularis | tm gpcr rhodopsin gpcr rhodopsin superfamily | 0.194 | 0.7399 | 0.7221 |
Echinococcus granulosus | biogenic amine 5HT receptor | 0.0882 | 0.1673 | 0.023 |
Loa Loa (eye worm) | hypothetical protein | 0.0768 | 0.1054 | 0.1054 |
Schistosoma mansoni | amine GPCR | 0.1304 | 0.3954 | 0.3241 |
Treponema pallidum | sodium- and chloride- dependent transporter | 0.2421 | 1 | 0.5 |
Trypanosoma cruzi | C-8 sterol isomerase, putative | 0.1122 | 0.2969 | 0.5 |
Echinococcus multilocularis | serotonin receptor | 0.0882 | 0.1673 | 0.1104 |
Loa Loa (eye worm) | hypothetical protein | 0.0882 | 0.1673 | 0.1673 |
Schistosoma mansoni | biogenic amine (5HT) receptor | 0.0882 | 0.1673 | 0.0691 |
Echinococcus granulosus | tm gpcr rhodopsin | 0.194 | 0.7399 | 0.6949 |
Schistosoma mansoni | norepinephrine/norepinephrine transporter | 0.2421 | 1 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.2421 | 1 | 1 |
Onchocerca volvulus | 0.2421 | 1 | 0.5 | |
Loa Loa (eye worm) | hypothetical protein | 0.2421 | 1 | 1 |
Echinococcus multilocularis | serotonin receptor | 0.0882 | 0.1673 | 0.1104 |
Loa Loa (eye worm) | hypothetical protein | 0.1122 | 0.2969 | 0.2969 |
Echinococcus multilocularis | serotonin transporter | 0.2421 | 1 | 1 |
Leishmania major | C-8 sterol isomerase-like protein | 0.1122 | 0.2969 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0882 | 0.1673 | 0.1673 |
Loa Loa (eye worm) | solute carrier family 6 member 4 | 0.2421 | 1 | 1 |
Echinococcus granulosus | serotonin transporter | 0.2421 | 1 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.2421 | 1 | 1 |
Brugia malayi | ERG2 and Sigma1 receptor like protein | 0.1122 | 0.2969 | 0.214 |
Loa Loa (eye worm) | hypothetical protein | 0.0768 | 0.1054 | 0.1054 |
Trypanosoma brucei | C-8 sterol isomerase, putative | 0.1122 | 0.2969 | 0.5 |
Schistosoma mansoni | sodium/chloride dependent transporter | 0.2421 | 1 | 1 |
Brugia malayi | Serotonin receptor | 0.1063 | 0.2649 | 0.1783 |
Loa Loa (eye worm) | hypothetical protein | 0.0691 | 0.0639 | 0.0639 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
Potency (functional) | = 1 um | PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Influenza NS1 Protein Function. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 13.1154 uM | PUBCHEM_BIOASSAY: Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 48 hour incubation. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488752, AID488774, AID504848, AID504850] | ChEMBL. | No reference |
Potency (functional) | 25.929 uM | PUBCHEM_BIOASSAY: Nrf2 qHTS screen for inhibitors. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID493153, AID493163, AID504648] | ChEMBL. | No reference |
Potency (functional) | = 28.1838 um | PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Aldehyde Dehydrogenase 1 (ALDH1A1). (Class of assay: confirmatory) [Related pubchem assays: 1030 (qHTS Validation Assay for Inhibitors of aldehyde dehydrogenase 1 (ALDH1A1))] | ChEMBL. | No reference |
Species name | Source | Reference | Is orphan |
---|---|---|---|
Plasmodium falciparum | ChEMBL23 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.